Sucralfate and Ifosfamide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sucralfate (sucralfate) and Ifosfamide (ifosfamide). Common drug interactions include gastrointestinal haemorrhage among females and granulocytopenia among males.

The phase IV clinical study analyzes what interactions people have when they take Sucralfate and Ifosfamide. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Sucralfate?

Sucralfate has active ingredients of sucralfate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 17,548 Sucralfate users. Check the latest studies of Sucralfate.

What is Ifosfamide?

Ifosfamide has active ingredients of ifosfamide. eHealthMe is studying from 21,285 Ifosfamide users. Check the latest studies of Ifosfamide.

On Jul, 16, 2026

11 people who take Sucralfate and Ifosfamide together, and have interactions are studied.

Sucralfate and Ifosfamide drug interactions.

What are the common drug interactions of Sucralfate and Ifosfamide, by gender? *:

female:

Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Mucosal inflammation (infection of mucous membrane)
Neutropenia (an abnormally low number of neutrophils)
Sepsis (a severe blood infection that can lead to organ failure and death)
Septic shock (shock due to blood infection)
Cardiomegaly (increased size of heart than normal)
Dizziness
Ejection fraction (the percentage of blood that is pumped out of a filled ventricle as a result of a heartbeat)
Hip fracture
Hypotension (abnormally low blood pressure)

male:

Granulocytopenia (lack of granulocyte)
Leukopenia (less number of white blood cells in blood)
Neutropenia (an abnormally low number of neutrophils)
Rash generalised (rash on most of body parts)
Skin lesion
Stomatitis (inflammation of mucous membrane of mouth)
Liver disorder (liver diseases)
Thrombocytopenia (decrease of platelets in blood)
Abnormal behaviour
Bradyphrenia (neurological term referring to the slowness of thought common to many disorders of the brain)

What are the common drug interactions of Sucralfate and Ifosfamide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Abnormal behaviour
Bradyphrenia (neurological term referring to the slowness of thought common to many disorders of the brain)
Gait disturbance
Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)
Speech disorder
Cardiomegaly (increased size of heart than normal)
Ejection fraction (the percentage of blood that is pumped out of a filled ventricle as a result of a heartbeat)
Palpitations (feelings or sensations that your heart is pounding or racing)

10-19:

Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Mucosal inflammation (infection of mucous membrane)
Neutropenia (an abnormally low number of neutrophils)
Sepsis (a severe blood infection that can lead to organ failure and death)
Septic shock (shock due to blood infection)

20-29:

n/a

30-39:

Confusional state
Death
Disorientation (disability in which the senses of time, direction, and recognition of people and places)
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Neurotoxicity (when the exposure to natural or artificial toxic substances, which are called neurotoxins, alters the normal activity of the nervous system)

40-49:

Granulocytopenia (lack of granulocyte)
Leukopenia (less number of white blood cells in blood)
Liver disorder (liver diseases)
Thrombocytopenia (decrease of platelets in blood)

50-59:

Herpes zoster
Neutropenia (an abnormally low number of neutrophils)
Rash generalised (rash on most of body parts)
Skin lesion
Stomatitis (inflammation of mucous membrane of mouth)

60+:

Hip fracture

What are the existing conditions these people have? *

Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 3 people, 27.27%
Pain: 2 people, 18.18%
Lymphoma (cancer that begins in immune system cells): 2 people, 18.18%
Heart Rate Increased: 1 person, 9.09%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 9.09%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 1 person, 9.09%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 9.09%
Constipation: 1 person, 9.09%
Diarrhea: 1 person, 9.09%
Dry Skin: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Sucralfate and Ifosfamide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously